JAZZ vs WLK · P/E 1988, rev $2.28B vs rev $5.92B
Jazz Pharmaceuticals PLC (JAZZ) versus Westlake Chemical Corporation (WLK) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Westlake Chemical Corporation (WLK) is a specialty chemicals company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported WLK revenue for 2026-06-30 was $5.92B. Net income was $91.0M. WLK currently screens at market cap $10.70B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. WLK currently screens at market cap $10.70B.
Not investment advice. Open the JAZZ and WLK stock pages for the full models.
Not investment advice.